(Hypertension. 1995;25:769-773.)
© 1995 American Heart Association, Inc.
Articles |
Deoxycorticosterone Acetate Plus Salt Induces Overexpression of Vascular Endothelin-1 and Severe Vascular Hypertrophy in Spontaneously Hypertensive Rats
From the Medical Research Council of Canada Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal (Québec, Canada).
Abstract Endothelin-1 gene expression is enhanced in the aorta and mesenteric arteries, and possibly other vessels, of deoxycorticosterone acetate (DOCA)–salt hypertensive rats. In contrast, endothelin-1 gene expression is normal or reduced in spontaneously hypertensive rats (SHR). Severe vascular hypertrophy is present in DOCA-salt hypertensive rats but not in SHR. In this study we investigated whether treatment of SHR with DOCA and salt would result in enhanced endothelin-1 expression and at the same time in severe vascular hypertrophy. Increased abundance of endothelin-1 mRNA was found in the aorta and the mesenteric arterial bed of SHR treated simultaneously with DOCA and salt but not when rats were treated with either separately. The wet weight of the aorta and of the mesenteric arterial bed, media thickness, media cross-sectional area, and media-to-lumen ratio of mesenteric small arteries of DOCA- salt–treated SHR were exaggerated beyond what could be explained by the elevation of blood pressure, relative to SHR treated with salt or with DOCA, which did not overexpress vascular endothelin-1. In conclusion, SHR may exhibit enhanced expression of the endothelin-1 gene in blood vessels when treated with DOCA and salt, and associated with this there is severe vascular hypertrophy. These data support the hypothesis of a role of endothelin-1 in vascular hypertrophy.
Key Words: endothelins • aorta • mesenteric arteries • vascular resistance • hypertrophy • deoxycorticosterone • sodium, dietary
This article has been cited by other articles:
 |
|
 |
|
  B. Fogelgren, S. Yang, I. C. Sharp, O. J. Huckstep, W. Ma, S. J. Somponpun, E. C. Carlson, C. F. T. Uyehara, and S. Lozanoff Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1166 - F1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Martinez-Lemus, M. A. Hill, and G. A. Meininger The Plastic Nature of the Vascular Wall: A Continuum of Remodeling Events Contributing to Control of Arteriolar Diameter and Structure Physiology, February 1, 2009; 24(1): 45 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Ko, F. Amiri, N. R. Pandey, D. Javeshghani, E. Leibovitz, R. M. Touyz, and E. L. Schiffrin Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1789 - H1795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Quaschning, F. Voss, K. Relle, P. Kalk, N. Vignon-Zellweger, T. Pfab, C. Bauer, F. Theilig, S. Bachmann, A. Kraemer-Guth, et al. Lack of Endothelial Nitric Oxide Synthase Promotes Endothelin-Induced Hypertension: Lessons from Endothelin-1 Transgenic/Endothelial Nitric Oxide Synthase Knockout Mice J. Am. Soc. Nephrol., March 1, 2007; 18(3): 730 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sun, R. A. Ahokas, S. K. Bhattacharya, I. C. Gerling, L. D. Carbone, and K. T. Weber Oxidative stress in aldosteronism Cardiovasc Res, July 15, 2006; 71(2): 300 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Tsai, M. Ohkita, and C. E. Gariepy Chronic high-sodium diet increases aortic wall endothelin-1 expression in a blood pressure-independent fashion in rats. Experimental Biology and Medicine, June 1, 2006; 231(6): 813 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Davis, G. Valacchi, E. Pagnin, Q. Shao, H. B. Gross, L. Calo, and W. Yokoyama Walnuts Reduce Aortic ET-1 mRNA Levels in Hamsters Fed a High-Fat, Atherogenic Diet J. Nutr., February 1, 2006; 136(2): 428 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. del Villar, C. J. G. Alonso, C. A. Feldstein, L. A. Juncos, and J. C. Romero Role of Endothelin in the Pathogenesis of Hypertension Mayo Clin. Proc., January 1, 2005; 80(1): 84 - 96. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Amiri, A. Virdis, M. F. Neves, M. Iglarz, N. G. Seidah, R. M. Touyz, T. L. Reudelhuber, and E. L. Schiffrin Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction Circulation, October 12, 2004; 110(15): 2233 - 2240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cardillo, U. Campia, M. Iantorno, and J. A. Panza Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Hypertensive Patients Hypertension, January 1, 2004; 43(1): 36 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Callera, R. M. Touyz, S. A. Teixeira, M. N. Muscara, M. H. C. Carvalho, Z. B. Fortes, D. Nigro, E. L. Schiffrin, and R. C. Tostes ETA Receptor Blockade Decreases Vascular Superoxide Generation in DOCA-Salt Hypertension Hypertension, October 1, 2003; 42(4): 811 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Pu, M. F. Neves, A. Virdis, R. M. Touyz, and E. L. Schiffrin Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling Hypertension, July 1, 2003; 42(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Park and E. L. Schiffrin ETA Receptor Antagonist Prevents Blood Pressure Elevation and Vascular Remodeling in Aldosterone-Infused Rats Hypertension, June 1, 2001; 37(6): 1444 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Tahawi, N. Orolinova, I. G. Joshua, M. Bader, and E. C. Fletcher Physiological and Genomic Consequences of Intermittent Hypoxia: Selected Contribution: Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats J Appl Physiol, May 1, 2001; 90(5): 2007 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fei, C. Viedt, U. Soto, C. Elsing, L. Jahn, and J. Kreuzer Endothelin-1 and Smooth Muscle Cells : Induction of Jun Amino-Terminal Kinase Through an Oxygen Radical-Sensitive Mechanism Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1244 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nava, V. Guarner, R. Posadas, I. Perez, and G. Banos Insulin-induced endothelin release and vasoreactivity in hypertriglyceridemic and hypertensive rats Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H399 - H404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Marano, M. Grigioni, S. Palazzesi, and A. U Ferrari Endothelin and mechanical properties of the carotid artery in Wistar-Kyoto and spontaneously hypertensive rats Cardiovasc Res, March 1, 1999; 41(3): 701 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E Ullian The role of corticosteroids in the regulation of vascular tone Cardiovasc Res, January 1, 1999; 41(1): 55 - 64. [Full Text] [PDF]
|
|
|
|
|
|
J. E. Donckier, P.-E. Massart, D. Hodeige, H. Van Mechelen, J.-P. Clozel, O. Laloux, J.-M. Ketelslegers, A. A. Charlier, and G. R. Heyndrickx Additional Hypotensive Effect of Endothelin-1 Receptor Antagonism in Hypertensive Dogs Under Angiotensin-Converting Enzyme Inhibition Circulation, August 19, 1997; 96(4): 1250 - 1256. [Abstract] [Full Text]
|
|
|
|
|
|
J.-M. Chillon, D. D. Heistad, and G. L. Baumbach Effects of Endothelin Receptor Inhibition on Cerebral Arterioles in Hypertensive Rats Hypertension, March 1, 1996; 27(3): 794 - 798. [Abstract] [Full Text]
|
|